Back
ESC Premium Access

A novel senolytic drug, seno-7284 ameliorates age-related cardiometabolic diseases

Session: Metabolic interfaces in vascular disease
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Speaker: Doctor G. Katsuumi (Tokyo, JP)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Goro Katsuumi

Juntendo University School of Medicine, Tokyo (Japan)
0 follower

5 more presentations in this session

Maternal high-fat diet exaggerates the development of diet-induced insulin resistance in adult offspring by enhancing pyroptosis through augmented gasdermin D-mediated pore formation

Speaker: Doctor N. Wada (Kyoto, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice

Speaker: Mr J. Merz (Freiburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

A distinct LDL profile to predict the risk of cardiovascular disease in familial hypercholesterolemia subjects: initial pre-clinical results

Speaker: Miss A. Hoogendoorn (Adelaide, AU)

Access
Abstract
Like
Thumbnail

Endothelial mitochondrial fragmentation contributes to vascular dysfunction in hypertension

Speaker: Associate Professor X. Zhang (Xi'an, CN)

Access
Like
Thumbnail

Endothelial autophagy triggers nuclear enrichment of miR-126-5p via a Mex3a-dependent pathway to confers endothelial protection and prevent atherosclerosis.

Speaker: Doctor D. Santovito (Munich, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Metabolic interfaces in vascular disease

Speakers: Doctor G. Katsuumi, Doctor N. Wada, Mr J. Merz, Miss A. Hoogendoorn, Associate Professor X. Zhang...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources